We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Counting on Company Execs to Address Quality Control Issues
FDA Counting on Company Execs to Address Quality Control Issues
December 7, 2010
Recent FDA warnings that it will hold pharma executives accountable for companies’ violations signify “somewhat of a change in philosophy,” for the agency as it works to identify and publicize industry-wide quality issues sooner, an FDA official says.